Literature DB >> 2212860

Posttransplant anti-glomerular basement membrane nephritis in related males with Alport syndrome.

C E Kashtan1, R J Butkowski, M M Kleppel, M R First, A F Michael.   

Abstract

This report describes the development of anti-glomerular basement membrane (GBM) glomerulonephritis after kidney transplantation in related males with Alport syndrome. Antibodies in sera from one of these patients stained normal GBM, Bowman's capsule, tubular basement membranes, and epidermal basement membranes but did not stain tissues from an unrelated Alport male. The target antigen was found to be a 26 kd peptide of the noncollagenous domain of basement membrane collagen. This study provides further evidence of the importance of abnormalities of basement membrane collagen in the pathogenesis of the Alport nephropathy. We speculate that certain mutations at the Alport locus, such as large intragenic deletions or frame-shift mutations, may be associated with failure to develop immune tolerance to epitopes on this 26kd peptide. In the setting of permissive immune response and regulation, transplantation of a normal kidney may result in the generation of anti-GBM antibodies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2212860

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  8 in total

Review 1.  Alport syndrome, basement membranes and collagen.

Authors:  C E Kashtan; M M Kleppel; R J Butkowski; A F Michael; A J Fish
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

Review 2.  Living donor kidney transplantation in patients with hereditary nephropathies.

Authors:  Patrick Niaudet
Journal:  Nat Rev Nephrol       Date:  2010-09-28       Impact factor: 28.314

3.  Aortic abnormalities in males with Alport syndrome.

Authors:  Clifford E Kashtan; Yoav Segal; Frances Flinter; David Makanjuola; Jay-Sen Gan; Terry Watnick
Journal:  Nephrol Dial Transplant       Date:  2010-05-21       Impact factor: 5.992

Review 4.  Approach to genetic testing to optimize the safety of living donor transplantation in Alport syndrome spectrum.

Authors:  Yasar Caliskan; Krista L Lentine
Journal:  Pediatr Nephrol       Date:  2022-01-27       Impact factor: 3.651

Review 5.  Recurrent primary disease and de novo nephritis following renal transplantation.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

6.  Deletions in the COL4A5 collagen gene in X-linked Alport syndrome. Characterization of the pathological transcripts in nonrenal cells and correlation with disease expression.

Authors:  C Antignac; B Knebelmann; L Drouot; F Gros; G Deschênes; M C Hors-Cayla; J Zhou; K Tryggvason; J P Grünfeld; M Broyer
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

Review 7.  Expert consensus guidelines for the genetic diagnosis of Alport syndrome.

Authors:  Judy Savige; Francesca Ariani; Francesca Mari; Mirella Bruttini; Alessandra Renieri; Oliver Gross; Constantinos Deltas; Frances Flinter; Jie Ding; Daniel P Gale; Mato Nagel; Michael Yau; Lev Shagam; Roser Torra; Elisabet Ars; Julia Hoefele; Guido Garosi; Helen Storey
Journal:  Pediatr Nephrol       Date:  2018-07-09       Impact factor: 3.714

8.  Genotype and Outcome After Kidney Transplantation in Alport Syndrome.

Authors:  Valentine Gillion; Karin Dahan; Jean-Pierre Cosyns; Pascale Hilbert; Michel Jadoul; Eric Goffin; Nathalie Godefroid; Martine De Meyer; Michel Mourad; Yves Pirson; Nada Kanaan
Journal:  Kidney Int Rep       Date:  2018-02-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.